Delivery of pro-inflammatory signals to the TME promotes tumor clearance.46,47 Site-specific incorporation of a STING agonist in the A12-VHHkappa conjugate improved rejection of MC38 tumors. The gene discussed is STING1; the disease is neoplasm.